Literature DB >> 22103667

Before and after endosomal escape: roles of stimuli-converting siRNA/polymer interactions in determining gene silencing efficiency.

Young Jik Kwon1.   

Abstract

Silencing the expression of a target gene by RNA interference (RNAi) shows promise as a potentially revolutionizing strategy for manipulating biological (pathological) pathways at the translational level. However, the lack of reliable, efficient, versatile, and safe means for the delivery of small interfering RNA (siRNA) molecules, which are large in molecular weight, negatively charged, and subject to degradation, has impeded their use in basic research and therapy. Polyplexes of siRNA and polymers are the predominant mode of siRNA delivery, but innovative synthetic strategies are needed to further evolve them to generate the desired biological and therapeutic effects. This Account focuses on the design of polymeric vehicles for siRNA delivery based on an understanding of the molecular interactions between siRNA and cationic polymers. Ideal siRNA/polymer polyplexes should address an inherent design dilemma for successful gene silencing: (1) Cationic polymers must form tight complexes with siRNA via attractive electrostatic interactions during circulation and cellular internalization and (2) siRNA must dissociate from its cationic carrier in the cytoplasm before they are loaded into RNA-induced silencing complex (RISC) and initiate gene silencing. The physicochemical properties of polymers, which dictate their molecular affinity to siRNA, can be programmed to be altered by intracellular stimuli, such as acidic pH in the endosome and cytosolic reducers, subsequently inducing the siRNA/polymer polyplex to disassemble. Specific design goals include the reduction of the cationic density and the molecular weight, the loss of branched structure, and changes in the hydrophilicity/hydrophobicity of the polymeric siRNA carriers, via acid-responsive degradation and protonation processes within the endosome and glutathione (GSH)-mediated reduction in the cytoplasm, possibly in combination with gradual stimuli-independent hydrolysis. Acetals/ketals are acid-cleavable linkages that have been incorporated into polymeric materials for stimuli-responsive gene and drug delivery. Tailoring the ketalization ratio and the molecular weight of ketalized branched PEI (K-BPEI) offers molecular control of the intracellular trafficking of siRNA/polymer polyplexes and, therefore, the gene silencing efficiency. The ketalization of linear PEI (K-LPEI) enhances gene silencing in vitro and in vivo by improving siRNA complexation with the polymer during circulation and cellular internalization, supplementing proton buffering efficiency of the polymer in the endosome, and facilitating siRNA dissociation from the polymer in the cytoplasm, in a serum-resistant manner. Spermine polymerization via ketalization and esterification for multistep intracellular degradations provides an additional polymeric platform for improved siRNA delivery and highly biocompatible gene silencing. The chemistry presented in this Account will help lay the foundation for the development of innovative and strategic approaches that advance RNAi technology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22103667     DOI: 10.1021/ar200241v

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  31 in total

1.  Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery.

Authors:  Christopher A Alabi; Kevin T Love; Gaurav Sahay; Hao Yin; Kathryn M Luly; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-23       Impact factor: 11.205

2.  Direct cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsules.

Authors:  Ying Jiang; Rui Tang; Bradley Duncan; Ziwen Jiang; Bo Yan; Rubul Mout; Vincent M Rotello
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-12       Impact factor: 15.336

Review 3.  Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.

Authors:  Fang Liu; Chunfang Wang; Yuantao Gao; Xiao Li; Feng Tian; Yongtao Zhang; Mingyang Fu; Pengfei Li; Yali Wang; Fei Wang
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

Review 4.  Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

Authors:  Peixuan Guo; Farzin Haque; Brent Hallahan; Randall Reif; Hui Li
Journal:  Nucleic Acid Ther       Date:  2012-08       Impact factor: 5.486

Review 5.  Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.

Authors:  Zhiyong Wang; Gang Liu; Hairong Zheng; Xiaoyuan Chen
Journal:  Biotechnol Adv       Date:  2013-09-05       Impact factor: 14.227

6.  Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.

Authors:  Maneesh Gujrati; Anthony Malamas; Tesia Shin; Erlei Jin; Yunlu Sun; Zheng-Rong Lu
Journal:  Mol Pharm       Date:  2014-07-14       Impact factor: 4.939

7.  Acid-degradable core-shell nanoparticles for reversed tamoxifen-resistance in breast cancer by silencing manganese superoxide dismutase (MnSOD).

Authors:  Soo Kyung Cho; Ali Pedram; Ellis R Levin; Young Jik Kwon
Journal:  Biomaterials       Date:  2013-09-19       Impact factor: 12.479

8.  Non-viral gene delivery via membrane-penetrating, mannose-targeting supramolecular self-assembled nanocomplexes.

Authors:  Lichen Yin; Ziyuan Song; Kyung Hoon Kim; Nan Zheng; Nathan P Gabrielson; Jianjun Cheng
Journal:  Adv Mater       Date:  2013-02-18       Impact factor: 30.849

9.  Melittin derived peptides for nanoparticle based siRNA transfection.

Authors:  Kirk K Hou; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

10.  The effect of side-chain functionality and hydrophobicity on the gene delivery capabilities of cationic helical polypeptides.

Authors:  Rujing Zhang; Nan Zheng; Ziyuan Song; Lichen Yin; Jianjun Cheng
Journal:  Biomaterials       Date:  2014-01-15       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.